Lung Cancer Heterogeneity and New Strategies for Drug Therapy.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Annual Review of Pharmacology and Toxicology

• Publication date

  2018-01-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1146/annurev-pharmtox-010716-104523PMID 28977762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endogenous DNA Damage as a Source of Genomic Instability in Cancer.

  2017cited by this paper
• Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

  2017cited by this paper
• Role of epigenetics in lung cancer heterogeneity and clinical implication.

  2017cited by this paper
• Detection of single cell heterogeneity in cancer.

  2017cited by this paper
• Metabolic reprogramming of carcinoma-associated fibroblasts and its impact on metabolic heterogeneity of tumors.

  2017cited by this paper
• The impact of heterogeneity in phosphoinositide 3-kinase pathway in human cancer and possible therapeutic treatments.

  2017cited by this paper
• Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors

  2017cited by this paper
• MiR-30 Family Potentially Targeting PI3K-SIAH2 Predicted Interaction Network Represents a Novel Putative Theranostic Panel in Non-small Cell Lung Cancer

  2017cited by this paper
• Intra-tumor heterogeneity from a cancer stem cell perspective

  2017cited by this paper
• Translating Germline Cancer Risk into Precision Prevention.

  2017cited by this paper
• The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor

  2017cited by this paper
• Single cell sequencing: a distinct new field

  2017cited by this paper
• Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.

  2017cited by this paper
• Piercing the "armor" of lung cancer with genome medicine.

  2017cited by this paper
• Stratifying tissue heterogeneity with scalable single-cell assays

  2017cited by this paper
• Intragenic DNA methylation prevents spurious transcription initiation

  2017cited by this paper
• Genomic mechanisms of transformation from chronic obstructive pulmonary disease to lung cancer.

  2017cited by this paper
• Genome analyses identify the genetic modification of lung cancer subtypes.

  2017cited by this paper
• Tomorrow's genome medicine in lung cancer.

  2017cited by this paper
• A global view of regulatory networks in lung cancer: An approach to understand homogeneity and heterogeneity.

  2017cited by this paper
• Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy.

  2017cited by this paper
• Correlation between mucin biology and tumor heterogeneity in lung cancer.

  2017cited by this paper
• Systems heterogeneity: An integrative way to understand cancer heterogeneity.

  2017cited by this paper
• Role of osteopontin in lung cancer evolution and heterogeneity.

  2017cited by this paper
• Treatments for EGFR‐mutant non‐small cell lung cancer (NSCLC): The road to a success, paved with failures

  2017cited by this paper
• Roles of immune microenvironment heterogeneity in therapy-associated biomarkers in lung cancer.

  2017cited by this paper
• Gene heterogeneity in metastasis of colorectal cancer to the lung.

  2017cited by this paper
• Biophysical aspect of phosphatidylinositol 3-kinase and role of oncogenic mutants (E542K & E545K)

  2016cited by this paper
• Protein-structure-guided discovery of functional mutations across 19 cancer types

  2016cited by this paper
• DNA-encoded chemistry: enabling the deeper sampling of chemical space

  2016cited by this paper
• Gene mutation‐based and specific therapies in precision medicine

  2016cited by this paper
• Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulation

  2016cited by this paper
• Activity-Based Proteomics Reveals Heterogeneous Kinome and ATP-Binding Proteome Responses to MEK Inhibition in KRAS Mutant Lung Cancer

  2016cited by this paper
• Could CRISPR be the solution for gene editing’s Gordian knot?

  2016cited by this paper
• Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems

  2016cited by this paper
• KRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapy

  2016cited by this paper
• Cancer treatment and survivorship statistics, 2016

  2016cited by this paper
• Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer

  2016cited by this paper
• Potentials of single‐cell biology in identification and validation of disease biomarkers

  2016cited by this paper
• Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents and in combined treatment with cisplatin in ovarian cancer

  2016cited by this paper
• New biomarkers and therapeutics can be discovered during COPD-lung cancer transition

  2016cited by this paper
• Clinical significance of T cell metabolic reprogramming in cancer

  2016cited by this paper
• Cancer Moonshot 2020: a new march of clinical and translational medicine

  2016cited by this paper
• Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

  2016cited by this paper
• Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues

  2016cited by this paper
• Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

  2016cited by this paper
• Identification of a Comprehensive Spectrum of Genetic Factors for Hereditary Breast Cancer in a Chinese Population by Next-Generation Sequencing

  2015cited by this paper
• Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric Cancer.

  2015cited by this paper
• Application of clinical bioinformatics in lung cancer-specific biomarkers

  2015cited by this paper
• Five critical elements to ensure the precision medicine

  2015cited by this paper
• Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.

  2015cited by this paper
• Identification of carcinogenic potential-associated molecular mechanisms in CD133+ A549 cells based on microRNA profiles

  2015cited by this paper
• Synergy in activating class I PI3Ks.

  2015cited by this paper
• Comprehensive genomic profiles of small cell lung cancer

  2015cited by this paper
• Global analyses of subtype- or stage-specific genes on chromosome 7 in patients with lung cancer

  2015cited by this paper
• Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition

  2015cited by this paper
• Genomic characterization of a large panel of patient-derived hepatocellular carcinoma xenograft tumor models for preclinical development

  2015cited by this paper
• Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma

  2014cited by this paper
• Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

  2014cited by this paper
• PIK3CA mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies

  2014cited by this paper
• DNA-encoded chemical libraries: advancing beyond conventional small-molecule libraries.

  2014cited by this paper
• Intratumor heterogeneity alters most effective drugs in designed combinations

  2014cited by this paper
• Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma.

  2014cited by this paper
• Gene polymorphisms and chronic obstructive pulmonary disease

  2013cited by this paper
• Precision medicine: an approach to R&D for delivering superior medicines to patients

  2012cited by this paper
• Versatile inhibitory effects of the flavonoid-derived PI3K/Akt inhibitor, LY294002, on ATP-binding cassette transporters that characterize stem cells

  2012cited by this paper
• Opportunities and challenges of disease biomarkers: a new section in the journal of translational medicine

  2012cited by this paper
• Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer

  2010cited by this paper
• Cell of origin of lung cancer

  2010cited by this paper
• Does hepatocyte growth factor/c-Met signal play synergetic role in lung cancer?

  2010cited by this paper
• A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.

  2009cited by this paper
• A major lung cancer susceptibility locus maps to chromosome 6q23-25.

  2004cited by this paper
• Autohepatocyte transplantation in a degradable collagen device in the bursa omentalis.

  1999cited by this paper
• Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice.

  1998cited by this paper
• Expression of p21(WAF1/CIP1/SDI1) and p53 in apoptotic cells in the adrenal cortex and induction by ischemia/reperfusion injury.

  1996cited by this paper

• Selenium in cancer management: exploring the therapeutic potential

  2025cites this paper
• Lung Cancer Organoids in Translational Research: Bridging Basic Science, Drug Development, and Clinical Therapeutics.

  2025cites this paper
• Stereo cell: A new approach to the next generation of clinical precision medicine

  2025cites this paper
• Unveiling the molecular and clinical risk landscape of second primary lung cancer in resected non-small cell lung cancer.

  2025cites this paper
• Oncogenic Activity and Sorafenib Sensitivity of ARAF p.S214C Mutation in Lung Cancer

  2025cites this paper
• Efficacy and safety of anlotinib monotherapy or combination therapy in the treatment of patients with advanced non-small cell lung cancer: a retrospective real-world study conducted in East China

  2025cites this paper
• TC2N maintains stem cell-like characteristics to accelerate lung carcinogenesis by blockade of dual specificity protein phosphatase 3

  2025cites this paper
• The X-Linked Tumor Suppressor TSPX Regulates Genes Involved in the EGFR Signaling Pathway and Cell Viability to Suppress Lung Adenocarcinoma

  2025cites this paper
• Exploring the prognostic analysis of autophagy and tumor microenvironment based on monocyte cells in lung cancer

  2024cites this paper
• Review Deciphering the Potential of Nanotherapeutics in Lung Cancer Management.

  2024cites this paper
• Clustering on hierarchical heterogeneous data with prior pairwise relationships

  2024cites this paper
• Preclinical Evaluation of [124I]-Sotorasib for the Imaging of Kirsten Rat Sarcoma G12C Mutant Tumors.

  2024cites this paper
• Navigating the Intersection of Technology and Depression Precision Medicine.

  2024cites this paper
• A scoring model for the expression of genes related to programmed cell death predicts immunotherapy response and prognosis in lung adenocarcinoma

  2024cites this paper
• Transcriptome analysis reveals PRKCA as a potential therapeutic target for overcoming cisplatin resistance in lung cancer through ferroptosis

  2024cites this paper
• Identification and experimental verification of an anoikis and immune related signature in prognosis for lung adenocarcinoma

  2023cites this paper
• IL-1 receptor-associated kinase 3 (IRAK3) in lung adenocarcinoma predicts prognosis and immunotherapy resistance: involvement of multiple inflammation-related pathways

  2023cites this paper
• Exploring the Significance of p53 Gene in Lung Cancer: Etiological Factors, Clinical Implications, and Therapeutic Approaches

  2023cites this paper
• Recent Progress in Drug Delivery Systems for Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer.

  2023cites this paper
• SUMOylation-triggered ALIX activation modulates extracellular vesicles circTLCD4-RWDD3 to promote lymphatic metastasis of non-small cell lung cancer

  2023influential citation
• Targeting TRIP13 for overcoming anticancer drug resistance (Review)

  2023cites this paper
• Construction of a prognostic model for lung adenocarcinoma based on heat shock protein-related genes and immune analysis

  2023cites this paper
• Identification of Fangchinoline as a novel autophagy inhibitor with an adjuvant of chemotherapy against lung cancer.

  2023cites this paper
• Development and In Vitro Evaluation of Crizotinib-Loaded Lipid–Polymer Hybrid Nanoparticles Using Box–Behnken Design in Non-small Cell Lung Cancer

  2023cites this paper
• Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study

  2023cites this paper
• The role of miR-143-3p/FNDC1 axis on the progression of non-small cell lung cancer

  2023cites this paper
• PU.1 negatively regulates tumorigenesis in non-small-cell lung cancer

  2023cites this paper
• Clinical Application Perspectives of Lung Cancers 3D Tumor Microenvironment Models for In Vitro Cultures

  2022cites this paper
• New strategies of clinical precision medicine

  2022cites this paper
• Marine toxin (+)‐chaetocin‐induced apoptosis of lung large cell carcinoma cell lines through cell cycle arrest via CDKN1A expression and replicative stress

  2022cites this paper
• Identification of metastasis-related long non-coding RNAs in lung cancer through a novel tumor mesenchymal score.

  2022cites this paper
• Neddylation pattern indicates tumor microenvironment characterization and predicts prognosis in lung adenocarcinoma

  2022cites this paper
• Multi-Target Potential of Berberine as an Antineoplastic and Antimetastatic Agent: A Special Focus on Lung Cancer Treatment

  2022cites this paper
• Differential MUC22 expression by epigenetic alterations in human lung squamous cell carcinoma and adenocarcinoma

  2021cites this paper
• Near-infrared light–triggered platelet arsenal for combined photothermal-immunotherapy against cancer

  2021cites this paper
• Management of clinical precision medicine

  2021cites this paper
• YBX1 Enhances Metastasis and Stemness by Transcriptionally Regulating MUC1 in Lung Adenocarcinoma

  2021cites this paper
• Transcriptomic Characterization Reveals Blood-based Molecular Signatures of NSCLC Patients in Response to Anti-PD-1 Therapy Combined with Chemotherapy

  2021cites this paper
• Fusion gene recurrence in non-small cell lung cancers and its association with cigarette smoke exposure

  2021cites this paper
• Intertumoural Heterogeneity and Branch Evolution of Synchronous Multiple Primary Lung Adenocarcinomas by Next-Generation Sequencing Analysis

  2021cites this paper
• Tanshinone IIA derivatives induced S-phase arrest through stabilizing c-myc G-quadruplex DNA to regulate ROS-mediated PI3K/Akt/mTOR pathway.

  2021cites this paper
• Correlation of transrenal DNA with non-small-cell lung cancer in noninvasive disease monitoring.

  2021cites this paper
• Genetic evolution to tyrosine kinase inhibitory therapy in patients with EGFR-mutated non-small-cell lung cancer

  2021cites this paper
• Efficacy and Safety of Anlotinib in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Study

  2021cites this paper
• Analysis of the Single-Cell Heterogeneity of Adenocarcinoma Cell Lines and the Investigation of Intratumor Heterogeneity Reveals the Expression of Transmembrane Protein 45A (TMEM45A) in Lung Adenocarcinoma Cancer Patients

  2021cites this paper
• Multidisciplinary therapy strategy of precision medicine in clinical practice

  2020cites this paper
• Immune Score Closely Associated With Tumor Microenvironment as A Prognostic Factor in Lung Adenocarcinoma

  2020cites this paper
• Monoacylglycerol Lipase Knockdown Inhibits Cell Proliferation and Metastasis in Lung Adenocarcinoma

  2020cites this paper
• Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging

  2020cites this paper
• Molecular mechanisms, off‐target activities, and clinical potentials of genome editing systems

  2020cites this paper
• Clinical Lipidomics In Understanding Of Lung Cancer: Opportunity And Challenge.

  2020cites this paper
• Towards the overcoming of anticancer drug resistance mediated by p53 mutations.

  2019cites this paper
• FOXD1 and Gal-3 Form a Positive Regulatory Loop to Regulate Lung Cancer Aggressiveness

  2019cites this paper
• PRC1 promotes cell proliferation and cell cycle progression by regulating p21/p27-pRB family molecules and FAK-paxillin pathway in non-small cell lung cancer

  2019cites this paper
• Screening common signaling pathways associated with drug resistance in non‐small cell lung cancer via gene expression profile analysis

  2019cites this paper
• Definition of clinical gene tests

  2019cites this paper
• Roles of NIPBL in maintenance of genome stability.

  2019cites this paper
• The polycomb group proteins functions in epithelial to mesenchymal transition in lung cancer.

  2019cites this paper
• The advances in CRISPR technology and 3D genome.

  2019cites this paper
• A tour of 3D genome with a focus on CTCF.

  2019cites this paper
• Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early-Invasive Lung Adenocarcinoma.

  2019cites this paper
• Interferon gamma induces inflammatory responses through the interaction of CEACAM1 and PI3K in airway epithelial cells

  2019cites this paper
• Can the Single Cell Make Biomedicine Different?

  2018cites this paper
• Emergence of Bias During the Synthesis and Amplification of cDNA for scRNA-seq.

  2018cites this paper
• A comparison of next-generation sequencing analysis methods for cancer xenograft samples.

  2018cites this paper
• Roles of Single Cell Systems Biomedicine in Lung Diseases.

  2018cites this paper
• Model-Informed Drug Development for Malaria Therapeutics

  2017cites this paper